4//SEC Filing
NovaBay Pharmaceuticals, Inc. 4
Accession 0001437749-16-031797
$NBYCIK 0001389545operating
Filed
May 12, 8:00 PM ET
Accepted
May 13, 2:55 PM ET
Size
4.4 KB
Accession
0001437749-16-031797
Insider Transaction Report
Form 4
SIECZKAREK MARK M
Director
Transactions
- Award
Common Stock
2016-05-09$1.91/sh+261,780$500,000→ 453,718 total
Footnotes (1)
- [F1]Share acquisition pursuant to a securities purchase agreement, which is one of a series of securities purchase agreements that the company entered into for the sale of an aggregate of 4,079,058 to 9 accredited investors. The company expects to sell another 2,094,241 pursuant to those same agreements on July 31, 2016.
Documents
Issuer
NovaBay Pharmaceuticals, Inc.
CIK 0001389545
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001389545
Filing Metadata
- Form type
- 4
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 2:55 PM ET
- Size
- 4.4 KB